Travere Therapeutics, Inc.
TVTX
60 insider filings · Latest: Sep 15, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Apr 15, 2026 | Apr 15 8:16 PM | Dube Eric M | Proposed Sale | 64,000 | $41.09 | $2.6M | — | View → |
| Apr 15, 2026 | Apr 15 8:15 PM | ELIZABETH REED | Proposed Sale | 6,785 | $41.83 | $283.8K | — | View → |
| Apr 15, 2026 | Apr 15 8:14 PM | CHRISTOPHER CLINE | Proposed Sale | 1,014 | $42.61 | $43.2K | — | View → |
| Apr 15, 2026 | Apr 15 8:13 PM | JULA INRIG | Proposed Sale | 1,018 | $42.61 | $43.4K | — | View → |
| Apr 14, 2026 | Apr 15 1:17 AM | Elizabeth E. Reed | Proposed Sale | 7,215 | $41.93 | $302.5K | — | View → |
| Apr 14, 2026 | Apr 15 12:53 AM | Jula Inrig | Proposed Sale | 7,215 | $41.93 | $302.5K | — | View → |
| Apr 14, 2026 | Apr 15 12:47 AM | Peter Heerma | Proposed Sale | 7,215 | $41.93 | $302.5K | — | View → |
| Apr 14, 2026 | Apr 15 12:40 AM | Christopher Cline | Proposed Sale | 7,239 | $41.93 | $303.5K | — | View → |
| Apr 14, 2026 | Apr 14 8:27 PM | GARY A LYONS | Proposed Sale | 8,000 | $30.70 | $245.6K | — | View → |
| Apr 14, 2026 | Apr 14 8:20 PM | CHRISTOPHER CLINE | Proposed Sale | 9 | $41.07 | $370 | — | View → |
| Apr 14, 2026 | Apr 14 8:19 PM | ELIZABETH REED | Proposed Sale | 37,500 | $41.07 | $1.5M | — | View → |
| Apr 14, 2026 | Apr 14 8:09 PM | ROY BAYNES | Proposed Sale | 32,750 | $41.29 | $1.4M | — | View → |
| Apr 14, 2026 | Apr 14 8:02 PM | SANDRA CALVIN | Proposed Sale | 21,977 | $41.07 | $902.6K | — | View → |
| Apr 13, 2026 | Apr 14 12:11 AM | Christopher Cline | Proposed Sale | 65 | $28.85 | $1.9K | — | View → |
| Apr 6, 2026 | Apr 7 10:17 PM | Roy D. BaynesDirector | Sale | 10,000 | $33.00 | $330.0K | 37,500(D) | View → |
| Apr 6, 2026 | Apr 6 8:06 PM | ROY BAYNES | Proposed Sale | 10,000 | $33.00 | $330.0K | — | View → |
| Apr 1, 2026 | Apr 2 9:55 PM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Sale | 60,000 | $30.93 | $1.9M | 432,886(D) | View → |
| Apr 1, 2026 | Apr 2 9:55 PM | Elizabeth E ReedChief Legal Officer and GC | Sale | 10,000 | $30.00 | $300.0K | 105,211(D) | View → |
| Apr 1, 2026 | Apr 1 8:13 PM | Dube Eric M | Proposed Sale | 60,000 | $30.93 | $1.9M | — | View → |
| Apr 1, 2026 | Apr 1 8:06 PM | ELIZABETH REED | Proposed Sale | 10,000 | $30.00 | $300.0K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 1, 2026 | May 4 8:27 PM | Roy D. BaynesDirector | Option Exercise | 9,750 | $6.82 | 9,750(D) | View → |
| Apr 14, 2026 | Apr 16 8:05 PM | LYONS GARY ADirector | Option Exercise | 8,000 | $16.33 | 0(D) | View → |
| Apr 14, 2026 | Apr 16 8:05 PM | Roy D. BaynesDirector | Option Exercise | 32,750 | $21.38 | 6,750(D) | View → |
| Apr 14, 2026 | Apr 16 8:05 PM | Sandra CalvinSVP, CHIEF ACCOUNTING OFFICER | Option Exercise | 15,250 | $22.40 | 19,500(D) | View → |
| Apr 14, 2026 | Apr 16 1:47 AM | Elizabeth E ReedChief Legal Officer and GC | Option Exercise | 37,500 | $19.08 | 20,000(D) | View → |
| Apr 6, 2026 | Apr 7 10:17 PM | Roy D. BaynesDirector | Option Exercise | 10,000 | $26.52 | 0(D) | View → |
| Apr 1, 2026 | Apr 2 9:55 PM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 60,000 | $15.46 | 0(D) | View → |
| Apr 1, 2026 | Apr 2 9:55 PM | Elizabeth E ReedChief Legal Officer and GC | Option Exercise | 10,000 | $15.46 | 45,000(D) | View → |
| Mar 16, 2026 | Mar 18 8:05 PM | Elizabeth E ReedChief Legal Officer and GC | Option Exercise | 10,000 | $19.08 | 10,000(D) | View → |
| Feb 20, 2026 | Feb 24 9:05 PM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 60,000 | $15.46 | 60,000(D) | View → |
| Feb 17, 2026 | Feb 19 9:10 PM | Elizabeth E ReedChief Legal Officer and GC | Option Exercise | 10,000 | $19.08 | 20,000(D) | View → |
| Jan 31, 2026 | Feb 4 2:30 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Grant/Award | 303,600 | $33.10 | 303,600(D) | View → |
| Jan 31, 2026 | Feb 4 2:30 AM | Jula InrigCHIEF MEDICAL OFFICER | Grant/Award | 75,000 | $33.10 | 75,000(D) | View → |
| Jan 31, 2026 | Feb 4 2:30 AM | Christopher R. ClineCHIEF FINANCIAL OFFICER | Grant/Award | 75,000 | $33.10 | 75,000(D) | View → |
| Jan 31, 2026 | Feb 4 2:30 AM | Peter HeermaCHIEF COMMERCIAL OFFICER | Grant/Award | 69,640 | $33.10 | 69,640(D) | View → |
| Jan 31, 2026 | Feb 4 2:30 AM | William E. RoteChief Research Officer | Grant/Award | 53,570 | $33.10 | 53,570(D) | View → |
| Jan 31, 2026 | Feb 4 2:30 AM | Sandra CalvinSVP, CHIEF ACCOUNTING OFFICER | Grant/Award | 20,160 | $33.10 | 20,160(D) | View → |
| Jan 31, 2026 | Feb 4 2:30 AM | Elizabeth E ReedChief Legal Officer and GC | Grant/Award | 66,960 | $33.10 | 66,960(D) | View → |
| Jan 27, 2026 | Jan 28 1:25 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 51,865 | $15.46 | 120,000(D) | View → |
| Jan 23, 2026 | Jan 28 1:25 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 8,135 | $15.46 | 171,865(D) | View → |